Dear customer, we are sorry but your browser doesn't support all necessary features for good site view. Please switch to one of the modern browsers (Chrome, Safari, Firefox).
Sotio

SCTbio

SCTbio is a stand-alone contract manufacturing organization offering full GMP services covering production of Advanced Therapy Medicinal Products (ATMPs) including genetically modified and viral vectors.

The SCTbio mission is to serve as the leading engine for the rapidly advancing field of cell and gene therapy by offering a superior approach to GMP manufacturing for its partners.

SCTbio was formed on July 1, 2021. The key company and personnel capabilities have been generated within SOTIO Group, during its more than 10 years of history of drug development and manufacturing. The company is a part of PPF Biotech network.

All of SOTIO’s cell and gene therapy GMP manufacturing capabilities have been outsourced to SCTbio, including our two manufacturing facilities located in Prague and in Beijing.

The company offers full services covering GMP production of Advanced Therapy Medicinal Products including genetically modified and viral vectors. SCTbio leverages a decade of experience in development of autologous cell-based products, product supply for clinical trials, GMP compliance for the full lifecycle of drug development, manufacturing, quality control, QA/QP release, storage and logistics services and process development services to deliver the highest quality collaboration for CDMO needs.

Contacts

SCTbio

Jankovcova 1518/2
170 00 Praha 7
Czech Republic